SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX

NEW YORK, Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Standard AVB Financial Corp. STND concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click here to learn more about your legal rights and options.

Eidos Therapeutics, Inc. EIDX concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc.  Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned. If you are an Eidos shareholder, click here to learn more about your rights and options. 

Watford Holdings Ltd. WTRE concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click here to learn more about your rights and options.  

American Renal Associates Holdings, Inc. ARA concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click here to learn more about your rights and options.  

Cancer Genetics, Inc. CGIX concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company. If you are a Cancer Genetics shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com  

https://www.halpersadeh.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-the-following-companies--stnd-eidx-wtre-ara-cgix-301196372.html

SOURCE Halper Sadeh LLP